BSE filing, NSE: VALIANTLAB. Summary written from the filing by ALFA Finder's alert engine.
Valiant Laboratories Ltd: key numbers
- Share price
- ₹125.82
- Market cap
- ₹683.4 Cr
- Revenue (annual)
- ₹237.5 Cr
- Net profit (annual)
- ₹-3.27 Cr
- P/E (TTM)
- 42.7×Sector 46.5×
- Promoter holding
- 74.94%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valiant Laboratories Ltd
All →Valiant Laboratories Other Announcement
Valiant Laboratories Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Valiant Laboratories Annual General Meeting
Valiant Laboratories Limited successfully conducted its 5th Annual General Meeting on September 28, 2026, transacting 18 agenda items including financial statements and various re-appointments.
Valiant Laboratories Acquisition Worth ₹0.7 Cr
Valiant Laboratories approved acquiring up to 1.01% equity in AMPYR Renewable Energy for ₹0.70 Crore. The investment enables captive solar power for its Tarapur plant.
- Value
- ₹0.70 Cr
- Execution
- 12 months from date of board approval
Valiant Laboratories Credit Rating
Valiant Laboratories Limited received a credit rating of IND BBB/Stable/IND A2 from India Ratings and Research for bank loan facilities totaling INR 56 Crore.
- Value
- ₹56.00 Cr
Valiant Laboratories Other Announcement
Valiant Laboratories Limited has dispatched letters to shareholders who have not registered their email addresses, providing access to the Annual Report and 5th AGM notice.
Valiant Laboratories Annual General Meeting
Valiant Laboratories Limited issued a notice for its Annual General Meeting scheduled for September 28, 2026, covering financial adoption, director appointments, and related party transaction approvals.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.